Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2/3 1

Status

Completed 41Recruiting 26Terminated 15Active not recruiting 11Unknown 7Not yet recruiting 5Withdrawn 3Suspended 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Genitourinary 5Gastrointestinal 1

Conditions

Prostatic Neoplasms 1Oligometastatic Prostate Carcinoma 1Oligo-metastatic Prostate Carcinoma 1Neoplasms 1Metastatic Hormone-Sensitive Prostate Cance 1Colorectal Neoplasms 1Castration-resistant Prostate Cancer 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1

Interventions

Gemcitabine 13Radiotherapy 12Androgen Antagonists 12Specimen Handling 9Magnetic Resonance Spectroscopy 9pembrolizumab 8toripalimab 7darolutamide 7Nivolumab 7Drug Therapy 7Docetaxel 7Radiosurgery 6Cystectomy 6enzalutamide 5apalutamide 5abiraterone 5Mitomycin 5Cisplatin 5Abiraterone Acetate 5disitamab vedotin 4Pluvicto 4Cyclophosphamide 4Axitinib 4tislelizumab 3fludarabine 3enfortumab vedotin 3cemiplimab 3cabozantinib 3Sunitinib 3Standard of Care 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Not yet recruiting × abiraterone × Genitourinary × Clear all
NCT07641855 2026-06-11

A Study of BL-B01D1 Combination Therapy in Patients With Metastatic Castration-resistant Prostate Cancer

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 2/3 Not yet recruiting
180 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT07620574 2026-06-02

Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

Exelixis

Phase 3 Not yet recruiting
5,000 enrolled
GastrointestinalGenitourinary

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT07154914 2025-09-04

A Novel Insight Into CRPC Progression and Immune: Evidence From Single-cell Spatial Transcriptome Multi-omics

Anhui Medical University

Not yet recruiting
396 enrolled
Genitourinary

Metastatic Hormone-Sensitive Prostate Cance

NCT05707468 2024-02-20

Neoadjuvant Radiohormonal Therapy for Oligometastatic Prostate Cancer

Changhai Hospital

Phase NA Not yet recruiting
200 enrolled
Genitourinary

Oligometastatic Prostate Carcinoma

NCT06198387 2024-01-10

Radiotherapy for Prostate and Oligo-metastatic Lesions in Patients With Low-burden Oligo-metastatic Prostate Cancer

Changhai Hospital

Phase NA Not yet recruiting
30 enrolled
Genitourinary

Oligo-metastatic Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡